510(k) Report

510(k) · Cleared

Cleared

SABER .014 PTA Dilatation Catheter; SABERX .014 PTA Dilatation Catheter

K221832510(k) TraditionalCleared Aug 22, 202260-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cordis US Corp · LIT Catheter, Angioplasty, Peripheral, Transluminal

Cleared on Aug 22, 2022 as substantially equivalent to K102035 (ClearStream Technologies, Ltd., 2010) and 1 other predicate after a 60-day review. Its family tree reaches back 4 generations to 2004.

Decided
Aug 22, 2022
Review
60 days
Class
Class II
Product code
LIT
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K042537 (2004). No later device cites it as a predicate yet.

  1. Root · 4 generations backK042537 Submarine Plus Percutaneous Transluminal Angioplasty (Pta) Catheter…Invatec Innovative Technologies · 2004
  2. 3 generations backK072947 Savvy Long and Sleek Peripheral Transluminal Angioplasty (Pta)…ClearStream Technologies, Ltd. · 2008
  3. 2 generations backK093139 Bantam,48XXXXXX, 50XXXXXXClearStream Technologies, Ltd. · 2009
  4. 1 generation backK102035 Sleek Otw Pta CathetersClearStream Technologies, Ltd. · 2010
  5. This deviceK221832 SABER .014 PTA Dilatation Catheter; SABERX .014 PTA Dilatation…Cordis US Corp · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K042537Submarine Plus Percutaneous Transluminal Angioplasty (Pta) Catheter, Model…Invatec Innovative Technologies2004—
−3K072947Savvy Long and Sleek Peripheral Transluminal Angioplasty (Pta) CathetersClearStream Technologies, Ltd.2008—
−2K093139Bantam,48XXXXXX, 50XXXXXXClearStream Technologies, Ltd.2009—
−1K102035Sleek Otw Pta CathetersClearStream Technologies, Ltd.2010—
0 (this device)K221832SABER .014 PTA Dilatation Catheter; SABERX .014 PTA Dilatation CatheterCordis US Corp2022—
FIG. 1 — Lineage of K221832, 2004–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIT device

  1. #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K102035Sleek Otw Pta Catheters
Summary page 4
…Name: Percutaneous Catheter (21 CFR 870.1250), Class II Product Code: LIT III. PREDICATE DEVICES SLEEK® OTW PTA Balloon Dilatation Catheter cleared on 12/01/2010 under K102035 and SLEEK® PTA Balloon Dilatation Catheter cleared on 02/08/2008 under K072947. Additional Reference Devices NANOCROSS™ ELITE OTW…
ClearStream Technologies, Ltd.2010—
*K072947Savvy Long and Sleek Peripheral Transluminal Angioplasty (Pta) Catheters
Summary page 4
…. PREDICATE DEVICES SLEEK® OTW PTA Balloon Dilatation Catheter cleared on 12/01/2010 under K102035 and SLEEK® PTA Balloon Dilatation Catheter cleared on 02/08/2008 under K072947. Additional Reference Devices NANOCROSS™ ELITE OTW PTA Dilatation Catheter .014 cleared on 7/18/201 under K141118 RAPIDCROSS™ PTA…
ClearStream Technologies, Ltd.2008—
†K141118Nanocross Eite 0.014 Over-the-Wire Pta Balloon Dilatation CatheterEv3, Inc.20141
†K130911Rapidcross Pta Rapid Exchange Balloon Dilatation CatheterEv3, Inc.2013—
†K131199Ultraverse RX Pta Balloon Dilatation CatheterBard Peripheral Vascular, Inc.2013—

Also cleared against K102035: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 3 companies; a new generation was cleared every 3.2 years on median.
  • None of the 4 ancestors has a recall.
  • 1 other device also cites its predicate K102035.

How does its category compare?

All LIT devices

LIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · LIT

3in 2025

2007: 62008: 82009: 72010: 132011: 102012: 192013: 142014: 122015: 192016: 112017: 92018: 62019: 42020: 92021: 42022: 82023: 62024: 62025: 32026 (partial year): 4
2007high 19 (2012) · low 3 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIT

90in 2025

2007: 64 days median2008: 53 days median2009: 29 days median2010: 78 days median2011: 82 days median2012: 29 days median2013: 79 days median2014: 90 days median2015: 112 days median2016: 116 days median2017: 57 days median2018: 118 days median2019: 40 days median2020: 125 days median2021: 61 days median2022: 122 days median2023: 167 days median2024: 43 days median2025: 90 days median2026 (partial year): 205 days median
2007high 205 (2026) · low 29 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIT

1in 2025

2009: 22010: 12013: 2, 2 Class I2014: 32016: 12018: 22019: 32021: 12024: 22025: 1
2007high 3 (2014) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LIT

2,073in 2025

2007: 5772008: 5132009: 6232010: 8092011: 8572012: 1,2772013: 1,2422014: 1,1782015: 1,2792016: 1,5292017: 2,0812018: 2,1882019: 2,4052020: 2,4432021: 2,4922022: 2,1552023: 1,8072024: 1,9132025: 2,073
2007high 2,492 (2021) · low 513 (2008)2025

MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076640577
20088530513
20097292623
201013781809
201110820857
2012192901,277
201314792 (2)1,242
2014129031,178
20151911201,279
20161111611,529
201795702,081
2018611822,188
201944032,405
2020912502,443
202146112,492
2022812202,155
2023616701,807
202464321,913
202539012,073
202642050—

What is it indicated for?

The SABERTM .014 and SABERXTM .014 PTA Dilatation Catheters are intended to dilate stenoses in the peripheral vasculature, including femoral, popliteal and infra popliteal arteries. The device is also indicated for postdilation of balloon-expandable and self-expanding stents in the peripheral vasculature.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K221832: SABER .014 PTA Dilatation Catheter; SABERX .014 PTA Dilatation Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K221832

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026